Long-term Outcome of Angioplasty Using a Wingspan Stent, Post-Stent Balloon Dilation and Aggressive Restenosis Management for Intracranial Arterial Stenosis

  • Seong-Cheol Park
  • Su Hee Cho
  • Moon-Kyu Kim
  • Ji-Eun Kim
  • Woo-Young Jang
  • Moon-Kyu Lee
  • Kwang-Deog Jo
  • Seung-Hoon YouEmail author
Original Article



To investigate the long-term outcome of stent angioplasty for symptomatic severe intracranial artery stenosis.


In this study 95 consecutive patients with intracranial atherosclerotic stenosis (>70%) underwent stent angioplasty using Wingspan stents. The primary endpoints were stroke or death within 30 days of the procedure and subsequent stroke attributed to the stented vessel. Disabling stroke was defined as stroke with a modified Rankin scale > 3. Secondary endpoints included transient ischemic attacks, contralateral stroke, nonstroke death, and other events. Patients underwent prestent balloon dilation with or without poststent balloon dilation, close restenosis follow-up, and selective retreatment, as required.


The mean follow-up duration was 34.9 ± 23.3 months. Primary endpoint events occurred in 23% of the patients. The median infarction volume was 2.6 ml, and 11 (68%) of 16 infarctions were <5 ml in volume. Disabling stroke occurred in 3% of patients. The primary endpoint rates were 17.9% within 30 days and 2.1% from 30 days to 1 year. Secondary endpoint events occurred in 27.3% of the patients. Mean stenosis was reduced from 76.8 ± 6.1% to 7.5 ± 13.4%. Of 80 patients who underwent angiographic follow-up, 11 (14%) experienced restenosis (≥50%) and 7 (9%) exhibited restenosis-related symptoms of transient ischemic attack. The rate of symptomatic restenosis was significantly higher in patients who underwent prestent balloon dilation alone than in patients who underwent prestent and poststent balloon dilation (p = 0.016).


The postprocedural stroke rate was similar to that observed in the SAMMPRIS study. Symptomatic restenosis may be reduced by poststent dilation, close angiographic follow-up, and retreatment.


Intracranial atherosclerosis Infarction Ischemic attack, transient Retreatment Stroke 



Digital subtraction angiography


Prestent ballooning


Prestent and poststent ballooning


Transient ischemic attack



This study was supported by Gangneung Asan Hospital research grant 2018-b09.

Author Contribution

All authors made substantial contribution to the design of the study and analysis and interpretation of the data in this work. All authors drafted and/or critically revised the manuscript, provided final approval of the version to be published, and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Compliance with ethical guidelines

Conflict of interest

S.-C. Park, S.H. Cho, M.-K. Kim, J.-E. Kim, W.-Y. Jang, M.-K. Lee, K.-D. Jo and S.-H. You declare that they have no competing interests.

Ethical standards

All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Written patient consent was waived by the local ethics committee due to the retrospective design. Gangneung Asan Hospital Institutional Review Board (certification number: 010-3595-9706).

Supplementary material

62_2019_793_MOESM1_ESM.docx (449 kb)
Temporal trends of primary endpoint events and disabling strokes.


  1. 1.
    Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993–1003.Google Scholar
  2. 2.
    Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305–16.Google Scholar
  3. 3.
    Zaidat OO, Klucznik R, Alexander MJ, Chaloupka J, Lutsep H, Barnwell S, Mawad M, Lane B, Lynn MJ, Chimowitz M; NIH Multi-center Wingspan Intracranial Stent Registry Study Group. The NIH registry on use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology. 2008;70:1518–24.CrossRefGoogle Scholar
  4. 4.
    Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Hanel RA, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke. 2007;38:881–7.CrossRefGoogle Scholar
  5. 5.
    Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, Berlis A, Reul J, Yu SC, Forsting M, Lui M, Lim W, Sit SP. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke. 2007;38:1531–7.CrossRefGoogle Scholar
  6. 6.
    Zhang L, Huang Q, Zhang Y, Deng B, Liu J, Hong B, Xu Y, Zhao W. A single-center study of Wingspan stents for symptomatic atherosclerotic stenosis of the middle cerebral artery. J Clin Neurosci. 2013;20:362–6.CrossRefGoogle Scholar
  7. 7.
    Levy EI1, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Pride L, Purdy P, Welch B, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella DJ. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery. 2007;61:644–50. discussion 50–1.CrossRefGoogle Scholar
  8. 8.
    Dorn F, Prothmann S, Wunderlich S, Liebig T. Stent angioplasty of intracranial stenosis: single center experience of 54 cases. Clin Neuroradiol. 2012;22:149–56.CrossRefGoogle Scholar
  9. 9.
    Zaidat OO, Fitzsimmons BF, Woodward BK, Wang Z, Killer-Oberpfalzer M, Wakhloo A, Gupta R, Kirshner H, Megerian JT, Lesko J, Pitzer P, Ramos J, Castonguay AC, Barnwell S, Smith WS, Gress DR; VISSIT Trial Investigators. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA. 2015;313:1240–8.CrossRefGoogle Scholar
  10. 10.
    Marks MP, Marcellus ML, Do HM, Schraedley-Desmond PK, Steinberg GK, Tong DC, Albers GW. Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol. 2005;26:525–30.PubMedGoogle Scholar
  11. 11.
    Jiang WJ, Wang YJ, Du B, Wang SX, Wang GH, Jin M, Dai JP. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke. 2004;35:1375–80.CrossRefGoogle Scholar
  12. 12.
    Shin YS, Kim BM, Suh SH, Jeon P, Kim DJ, Kim DI, Kim BS, Kim KH, Heo JH, Nam HS, Kim YD. Wingspan stenting for intracranial atherosclerotic stenosis: clinical outcomes and risk factors for in-stent restenosis. Neurosurgery. 2013;72:596–604. discussion 604.CrossRefGoogle Scholar
  13. 13.
    Jiang WJ, Yu W, Du B, Gao F, Cui LY. Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting. Stroke. 2011;42:1971–5.CrossRefGoogle Scholar
  14. 14.
    Yu SC, Leung TW, Lee KT, Hui JW, Wong LK. Angioplasty and stenting of atherosclerotic middle cerebral arteries with Wingspan: evaluation of clinical outcome, restenosis, and procedure outcome. AJNR Am J Neuroradiol. 2011;32:753–8.CrossRefGoogle Scholar
  15. 15.
    Li TX, Gao BL, Cai DY, Wang ZL, Zhu LF, Xue JY, Bai WX, He YK, Li L. Wingspan Stenting for severe symptomatic Intracranial atherosclerotic Stenosis in 433 patients treated at a single medical center. PLoS ONE. 2015;10:e139377.Google Scholar
  16. 16.
    Turk AS, Levy EI, Albuquerque FC, Pride GL Jr, Woo H, Welch BG, Niemann DB, Purdy PD, Aagaard-Kienitz B, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella D. Influence of patient age and stenosis location on wingspan in-stent restenosis. AJNR Am J Neuroradiol. 2008;29:23–7.CrossRefGoogle Scholar
  17. 17.
    Derdeyn CP, Fiorella D, Lynn MJ, Turan TN, Cotsonis GA, Lane BF, Montgomery J, Janis LS, Chimowitz MI; SAMMPRIS Investigators. Nonprocedural symptomatic infarction and in-Stent Restenosis after Intracranial Angioplasty and Stenting in the SAMMPRIS trial (Stenting and aggressive medical management for the prevention of recurrent stroke in Intracranial Stenosis). Stroke. 2017;48:1501–6.CrossRefGoogle Scholar
  18. 18.
    Vajda Z, Güthe T, Perez MA, Heuschmid A, Schmid E, Bäzner H, Henkes H. Neurovascular in-stent stenoses: treatment with conventional and drug-eluting balloons. AJNR Am J Neuroradiol. 2011;32:1942–7.CrossRefGoogle Scholar
  19. 19.
    Chimowitz MI, Lynn MJ, Turan TN, Fiorella D, Lane BF, Janis S, Derdeyn CP; SAMMPRIS Investigators. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011;20:357–68.CrossRefGoogle Scholar
  20. 20.
    Connors JJ 3rd, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg. 1999;91:415–23.PubMedGoogle Scholar
  21. 21.
    Yu J, Wang L, Deng JP; JLi, Gao L, Zhang T, Zhao ZW, Gao GD. Treatment of symptomatic intracranial atherosclerotic stenosis with a normal-sized gateway() balloon and wingspan() stent. J Int Med Res. 2010;38:1968–74.PubMedGoogle Scholar
  22. 22.
    Albuquerque FC, Levy EI, Turk AS, Niemann DB, Aagaard-Kienitz B, Pride GL Jr, Purdy PD, Welch BG, Woo HH, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella DJ. Angiographic patterns of Wingspan in-stent restenosis. Neurosurgery. 2008;63:23–7. discussion 27–8.CrossRefGoogle Scholar
  23. 23.
    Zhang L, Huang Q, Zhang Y, Liu J, Hong B, Xu Y, Zhao W. Wingspan stents for the treatment of symptomatic atherosclerotic stenosis in small intracranial vessels: safety and efficacy evaluation. AJNR Am J Neuroradiol. 2012;33:343–7.CrossRefGoogle Scholar
  24. 24.
    Berkefeld J, Zanella FE. Intracranial stenting of atherosclerotic stenoses. Clin Neuroradiol. 2009;19:38–44.CrossRefGoogle Scholar
  25. 25.
    Shin YS, Kim SY, Bang OY, Jeon P, Yoon SH, Cho KH, Cho KG. Early experiences of elective stenting for symptomatic stenosis of the M1 segment of the middle cerebral artery: reports of three cases and review of the literature. J Clin Neurosci. 2003;10:53–9.CrossRefGoogle Scholar
  26. 26.
    Brodie BR, Cooper C, Jones M, Fitzgerald P, Cummins F; Postdilatation Clinical Compartative Study (POSTIT) Investigators. Is adjunctive balloon postdilatation necessary after coronary stent deployment? Final results from the POSTIT trial. Catheter Cardiovasc Interv. 2003;59:184–92.CrossRefGoogle Scholar
  27. 27.
    Siddiq F, Chaudhry SA, Khatri R, Rodriguez GJ, Tummala R, Suri MF, Qureshi AI. Rate of postprocedural stroke and death in SAMMPRIS trial-eligible patients treated with intracranial angioplasty and/or stent placement in practice. Neurosurgery. 2012;71:68–73.CrossRefGoogle Scholar
  28. 28.
    Derdeyn CP, Fiorella D, Lynn MJ, Barnwell SL, Zaidat OO, Meyers PM, Gobin YP, Dion J, Lane BF, Turan TN, Janis LS, Chimowitz MI; SAMMPRIS Trial Investigators. Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. J Neurointerv Surg. 2013;5:528–33.Google Scholar
  29. 29.
    Tarlov N, Jahan R, Saver JL, Sayre JW, Ali LK, Kim D, et al.Tarlov N1, Jahan R, Saver JL, Sayre JW, Ali LK, Kim D, Duckwiler GR, Tateshima S, Viñuela F, Liebeskind DS.Tarlov N, Jahan R, Saver JL, Sayre JW, Ali LK, Kim D, et al.reatment of high risk symptomatic intracranial atherosclerosis with balloon mounted coronary stents and Wingspan stents: single center experience over a 10 year period. J Neurointerv Surg. 2012;4:34–9.Google Scholar
  30. 30.
    Habib A, Finn AV. Endothelialization of drug eluting stents and its impact on dual anti-platelet therapy duration. Pharmacol Res. 2015;93:22–7.CrossRefGoogle Scholar
  31. 31.
    Costalat V, Maldonado IL, Vendrell JF, Riquelme C, Machi P, Arteaga C, Turjman F, Desal H, Sedat J, Bonafé A. Endovascular treatment of symptomatic intracranial stenosis with the Wingspan stent system and Gateway PTA balloon: a multicenter series of 60 patients with acute and midterm results. J Neurosurg. 2011;115:686–93.PubMedGoogle Scholar
  32. 32.
    Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol. 2000;21:643–6.PubMedGoogle Scholar
  33. 33.
    Obeid T, Arnaoutakis DJ, Arhuidese I, Qazi U, Abularrage CJ, Black J, Perler B, Malas M. Poststent ballooning is associated with increased periprocedural stroke and death rate in carotid artery stenting. J Vasc Surg. 2015;62:616–23.CrossRefGoogle Scholar
  34. 34.
    Zhang ZJ, Marroquin OC, Stone RA, Weissfeld JL, Mulukutla SR, Selzer F, Kip KE. Differential effects of post-dilation after stent deployment in patients presenting with and without acute myocardial infarction. Am Heart J. 2010;160:979–86.Google Scholar
  35. 35.
    Blackman DJ, Porto I, Shirodaria C, Channon KM, Banning AP. Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis. Am J Cardiol. 2004;94:922–5.CrossRefGoogle Scholar
  36. 36.
    Zhang ZJ, Ma L, Wan J, Kip KE. Stent post-dilation for patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv. 2014;84:682–3.CrossRefGoogle Scholar
  37. 37.
    von Schoenfeldt P, Krützelmann A, Bußmeyer M, Mpotsaris A, Rosenkranz M, Fiehler J, Weber W, Buhk JH. Elective treatment of intracranial stenosis with the balloon-expandable Pharos Vitesse stent: 30-day stroke rate and complications. J Neurointerv Surg. 2015;7:188–93.CrossRefGoogle Scholar
  38. 38.
    Kessler IM, Mounayer C, Piotin M, Spelle L, Vanzin JR, Moret J. The use of balloon-expandable stents in the management of intracranial arterial diseases: a 5-year single-center experience. AJNR Am J Neuroradiol. 2005;26:2342–8.PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of NeurosurgeryGangneung Asan Hospital, University of Ulsan College of MedicineGangneung, Gangwon-doKorea (Republic of)
  2. 2.Department of NeurologyGangneung Asan Hospital, University of Ulsan College of MedicineGangneungKorea (Republic of)

Personalised recommendations